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Troponin I (TnI) is a major regulator of cardiac muscle contraction and relaxation.
During physiological and pathological stress, TnI is differentially phosphorylated at
multiple residues through different signaling pathways to match cardiac function to
demand. The combination of these TnI phosphorylations can exhibit an expected
or unexpected functional integration, whereby the function of two phosphorylations
are different than that predicted from the combined function of each individual
phosphorylation alone. We have shown that TnI Ser-23/24 and Ser-150 phosphorylation
exhibit functional integration and are simultaneously increased in response to cardiac
stress. In the current study, we investigated the functional integration of TnI Ser-23/24
and Ser-150 to alter cardiac contraction. We hypothesized that Ser-23/24 and Ser-150
phosphorylation each utilize distinct molecular mechanisms to alter the TnI binding
affinity within the thin filament. Mathematical modeling predicts that Ser-23/24 and
Ser-150 phosphorylation affect different TnI affinities within the thin filament to distinctly
alter the Ca2+-binding properties of troponin. Protein binding experiments validate
this assertion by demonstrating pseudo-phosphorylated Ser-150 decreases the affinity
of isolated TnI for actin, whereas Ser-23/24 pseudo-phosphorylation is not different
from unphosphorylated. Thus, our data supports that TnI Ser-23/24 affects TnI-TnC
binding, while Ser-150 phosphorylation alters TnI-actin binding. By measuring force
development in troponin-exchanged skinned myocytes, we demonstrate that the
Ca2+ sensitivity of force is directly related to the amount of phosphate present
on TnI. Furthermore, we demonstrate that Ser-150 pseudo-phosphorylation blunts
Ser-23/24-mediated decreased Ca2+-sensitive force development whether on the
same or different TnI molecule. Therefore, TnI phosphorylations can integrate across
troponins along the myofilament. These data demonstrate that TnI Ser-23/24 and
Ser-150 phosphorylation regulates muscle contraction in part by modulating different TnI
interactions in the thin filament and it is the combination of these differential mechanisms
that provides understanding of their functional integration.
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INTRODUCTION
Contraction and relaxation of the heart is fundamentally
dependent on the conversion of the dynamic rise and fall in
intracellular cytosolic Ca2+ into force production (Kobayashi
and Solaro, 2005). The binding of Ca2+ to troponin (Tn) activates
the myofilament allowing the interaction of myosin with actin,
the generation of force and contraction. Calcium regulation of
the myofilament through this binding event is not a simple “on
and off” switch (Solzin et al., 2007; Davis and Tikunova, 2008;
Biesiadecki and Davis, 2014; Davis et al., 2016). Rather, activation
and deactivation are both active processes that involve a number
of dynamic and complex protein-protein interactions (Manning
et al., 2011). Each of these dynamic interactions have the potential
to modulate similar and/or different myofilament contraction
and relaxation functions (Biesiadecki et al., 2014; Chung et al.,
2016; Janssen et al., 2016). Thus, the myofilament response to
Ca2+ can be intricately manipulated through Tn to regulate
cardiac function and improve resulting in an improved outcome
in cardiac disease (Li et al., 2010; Alves et al., 2014; Shettigar et al.,
2016).
The phosphorylation of troponin I (TnI) represents a key
mechanism in modulating the myofilament response to Ca2+
(Solaro et al., 1976; Solaro and Kobayashi, 2011; Liu et al.,
2014; Nixon et al., 2014). One of the most physiologically and
pathologically relevant Tn phosphorylations is the adrenergic
mediated protein kinase A phosphorylation of TnI at serines 23
and 24 (Ser-23/24). TnI Ser-23/24 phosphorylation contributes
significantly to Ca2+ regulation of the myofilament, resulting
in decreased Ca2+-sensitive force production and accelerated
myofilament relaxation (Kranias and Solaro, 1982; de Tombe
and Stienen, 1995; Herron et al., 2001; Kentish et al., 2001;
Sakthivel et al., 2005; Biesiadecki et al., 2007; Ramirez-Correa
et al., 2010). In addition to Ser-23/24, TnI can undergo
phosphorylation on at least 12 additional residues as the end
result of different signaling pathways (Zhang et al., 2012). A
large subset of literature has described the effects many of
these phosphorylations impart on cardiac function through
altering the Ca2+ sensitive regulation of force production in
isolation. Although a single phosphorylation is sufficient to alter
cardiac function, the heart simultaneously contains multiple
TnI phosphorylations that can be independently altered in
response to physiological and pathological stress (Pi et al.,
2003; Nixon et al., 2014; Lang et al., 2015). Therefore, it
is not the isolated effect of a single TnI phosphorylation
that is responsible for overall cardiac regulation, but rather
the simultaneous presence of multiple TnI phosphorylations
that combine to exhibit expected or unexpected functional
integration. The significance of these multiple phosphorylations
results in a functional integration as demonstrated by the finding
that the contractile effects of TnI Ser-23/24 phosphorylation
are dependent on the myofilament phosphorylation background
(Biesiadecki et al., 2007; Kooij et al., 2010; Nixon et al.,
2012; Salhi et al., 2014; Lang et al., 2015). The mechanisms
underlying how combined TnI phosphorylations integrate to
Abbreviations: Calcium, Ca2+; Tn, troponin; TnI, troponin I; WT, wild-type.
regulate the myofilament response to Ca2+ remain poorly
understood.
The integrated function of multiple TnI phosphorylations
is significant in cardiac disease (Zhang et al., 2012). We have
demonstrated that the phosphorylation of TnI at Ser-23/24
and Ser-150 are both significantly increased in response to
ischemic conditions following a myocardial infarction (Nixon
et al., 2014). At first glance this seems paradoxical in that Ser-
23/24 phosphorylation decreases while Ser-150 phosphorylation
increases Ca2+-sensitivity (Nixon et al., 2012; Oliveira et al.,
2012). However, the combination of Ser-23/24 and Ser-150
phosphorylation exhibit functional integration by differentially
regulating cardiac function from that of either phosphorylation
alone, retaining contractile force (normal Ca2+ sensitivity) but
accelerating relaxation (accelerated Ca2+ dissociation) (Nixon
et al., 2012, 2014). This and others’ findings demonstrate
the significance of TnI phosphorylation integration to cardiac
function during disease (Kooij et al., 2010; Boontje et al., 2011;
Taglieri et al., 2011; Salhi et al., 2014). Ultimately, elucidating
the different molecular mechanisms utilized during simultaneous
TnI phosphorylation will provide insight into the regulatory
protein interactions that can be therapeutically targeted, such
as by altered phosphorylation, to modulate contraction and
relaxation in cardiac disease.
In the current study, we sought to investigate the molecular
mechanisms utilized by Ser-23/24 and Ser-150 phosphorylation
to modulate contraction both individually and when integrated.
Based on our previous work, we hypothesized that Ser-23/24
and Ser-150 differentially alter the binding affinities of TnI
within the thin filament to elicit functional integration. By
employing mathematical modeling and protein-protein binding
experiments, we identified that Ser-23/24 or Ser-150 pseudo-
phosphorylation eachmodulate different TnI binding affinities in
the thin filament. TnI Ser-150 pseudo-phosphorylation decreases
the affinity of TnI for actin, which is unaffected by Ser-23/24
pseudo-phosphorylation. Through force-Ca2+ measurements
in Tn-exchanged skinned myocytes we demonstrate that the
magnitude of pseudo-phosphorylation-dependent Ca2+ sensitive
force development is directly related to the amount of
TnI pseudo-phosphorylation present at Ser-23/24 or Ser-150.
We further demonstrate that these pseudo-phosphorylations
function similarly regardless of whether they are present on the
same or different TnI molecules. These data demonstrate that
TnI Ser-23/24 and Ser-150 phosphorylations affect distinct TnI
interactions in the thin filament to result in differential regulation
of the steady-state and kinetics of contraction.
MATERIALS AND METHODS
Mathematical Model
The thin filament interactions responsible for the steady-state
TnC Ca2+ binding and kinetic Ca2+ dissociation from TnC
for each phosphorylated TnI were determined by solving the
mathematical model described by Siddiqui et al. (2016). Briefly,
this model describes Ca2+ mediated thin filament regulation
based on six biochemical states of TnC. The TnC states are
described by a series of first order differential equations. Reaction
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rate constants for each TnI phosphorylation were solved using
Scilab computation to approximate the previously determined
Tn and thin filament biochemical determinants (Ca2+-sensitivity
and Ca2+ dissociation Nixon et al., 2012, 2014) for each TnI
phosphorylation.
cDNA Constructs
All cardiac TnI amino acid residue numbers presented in this
manuscript are given according to the human sequence including
the first methionine. Site-directed mutagenesis (QuickChange
Lightning, Agilent, Santa Clara, CA) was conducted according
to manufacturer’s instructions to generate cDNA constructs
encoding human TnI pseudo-phosphorylations: Ser-150 to Asp
(S150D), Ser-23/24 to Asp (S23/24D), Ser-23/24 to Asp with Ser-
150 to Asp (S23/24/150D). All resultant constructs were verified
by DNA sequencing.
Protein Expression and Purification
Plasmids encoding the individual recombinant human cardiac
Tn subunits were transformed and expressed in Escherichia coli
and purified to homogeneity as previously described (Sumandea
et al., 2003; Kobayashi et al., 2005; Kobayashi and Solaro,
2006; Nixon et al., 2012). Cardiac Tn complexes were prepared
and reconstituted by sequential dialysis as previously described
(Kobayashi and Solaro, 2006; Biesiadecki et al., 2007; Nixon et al.,
2014).
Solid-Phase Protein Binding
ELISA-based solid-phase protein binding assays were
conducted as previously described to determine the effect of
phosphorylation to alter TnI binding to actin compared to that
of non-phosphorylated TnI (Biesiadecki and Jin, 2011). Briefly,
2µM F-actin dissolved in Buffer A (in mM: 150KCl, 3MgCl2,
10 MOPS, pH 7.0) was used to coat a 96-well microtiter plate
in 100µL/well at 4◦C overnight. Unbound actin was washed
with Buffer T (Buffer A containing 0.1% Tween-20). Following
washes, the wells were blocked with Buffer A containing 1% BSA.
Following removal of blocking solution, serial dilutions of TnI
WT or phosphomimetics (S23/24D, S150D, or S23/24/150D)
were incubated in 100µL/well for 2 h at room temperature.
The wells were then washed and bound TnI was quantified by
ELISA using a mouse anti-cardiac TnI antibody (Fitzgerald;
clone C5) and appropriate HRP-conjugated secondary antibody.
Following the addition of H2O2-ABTS (2,2
′-azino-bis(3-
ethylbenzthiazoline-6-sulphonic acid) substrate solution, the
absorbance at 405 nm was monitored over the linear course of
color development. Protein binding assays were conducted in
triplicate wells and repeated. Each assay contained wells that
were coated with F-actin but incubated with buffer in the absence
of TnI as a negative control.
Myocyte Force Production
All animal protocols and procedures were performed in
accordance with National Institutes of Health guidelines and
approved by the Institutional Laboratory Animal Care and Use
Committee at The Ohio State University. Steady-state Ca2+-
sensitive force development was measured in Tn-exchange
permeabilized rat myocytes as described previously (Salhi et al.,
2014). Briefly, following mechanical isolation from frozen rat
ventricular tissue, cardiac myocyte preparations were skinned
by resuspension in relaxing solution (in mM; 97.92 KOH, 6.24
ATP, 10 EGTA, 10 Na2CrP, 47.58 Kprop, 6.54 MgCl2, 100 BES,
pH 7.0) containing 1% peroxide-free Triton X-100 (Anapoe-
X-100, Anatrace, Maumee, OH) with incubation at room
temperature for 10 min rocking. Following skinning, myocytes
were centrifuged and immediately resuspended for Tn exchange.
Exchange of exogenous recombinant human cardiac Tn into
skinned rat myocytes was performed as described previously
by incubating myocytes in exchange buffer (in mM; 200KCl,
5MgCl2, 1 DTT, 5 EGTA, 20 MOPS, pH 6.5) containing 13 uM
column purified Tn overnight at 4◦C (Sumandea et al., 2003;
Biesiadecki et al., 2007; Nixon et al., 2012). Exchange with
Tn WT, Tn S23/24D, Tn S150D, and Tn S23/24/150D groups
was conducted by incubating skinned myocytes overnight in
exchange solution containing the single purified Tn complex
indicated. Exchange with Tn WT+S23/24D, Tn WT+S150D,
and Tn S23/24D+S150D groups was conducted by incubating
skinned myocytes overnight in exchange solution containing an
equal molar ratio of the two purified indicated Tn complexes to
a final total Tn of 13 uM. Calcium regulated force development
in skinned Tn exchanged rat ventricular myocyte preparations
was performed similar to that previously described (Salhi et al.,
2014). Briefly, Tn exchanged myocytes were attached to two
micro-needles using aquarium sealant (Marineland, Noblesville,
IN) and sarcomere length was adjusted to 2.2 um by visualization
on a calibrated monitor. The perfusion pipette of a constant
perfusion control system (VC-8M Eight Channel Mini-Valve
Perfusion System, Warner Instruments, Hamden, CT) was then
placed close to the myocyte such that the outflow perfused
the entire myocyte. Experiments were performed by flowing a
series of activating mixtures consisting of relaxing and activating
solution over the myocyte. Activating solution was identical
in composition to relaxing solution but containing varied free
Ca2+ concentration (pCa 10.0 to 4.5) (Fabiato and Fabiato,
1979). Developed force wasmeasured at each activating perfusion
followed by perfusion with relaxing solution. The activating
developed force was subtracted from the subsequent relax
perfused force measure. Time-dependent force rundown was
determined by comparison of the first developed maximal force
to the force developed upon final maximal activation at the end
of the experiment. Any cell exhibiting greater than 20% force
rundown was discarded. Cell cross-sectional area was calculated
after the force experiment on a calibrated monitor as previously
described (Salhi et al., 2014). Force-pCa curves were fit using
a modified Hill-equation (Biesiadecki et al., 2007; Nixon et al.,
2012). Experiments were conducted at room temperature. Data
were acquired with custom-made LabView software and analyzed
using Igor Pro.
Protein Electrophoresis and Western Blot
Skinned myocytes were solubilized in denaturing buffer (2%
SDS, 0.1% bromophenol blue, 10% glycerol and 50 mM
Tris-HCl, pH 6.8), heated for 5 min at 80◦C and clarified
by centrifugation for 5 min. SDS-PAGE and Western blot
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were carried similar to that previously described (Biesiadecki
et al., 2010; Liu et al., 2012; Nixon et al., 2012). Briefly,
proteins were separated on 12% (29:1) Laemmli gel and
transferred to PVDF. Following blocking with 1% BSA in
TBS resultant membranes were incubated with a mouse anti-
cardiac TnI antibody (Fitzgerald; clone C5). Following washes,
membranes were incubated with a Dylight labeled fluorescent
secondary antibody (Jackson ImmunoResearch Laboratories,
Inc, West Grove, PA) and visualized on a Typhoon 9410
imager (GEHealthcare, Piscataway, NJ). Differential migration of
endogenous mouse TnI versus exogenous exchanged human TnI
allowed for quantification by densitometry analysis. In groups
where two different Tn complexes were exchanged the amount of
total exogenous incorporation was determined and the exchange
of the two complexes considered similar.
Data Processing and Statistical Analysis
Data are presented as mean ± the standard error of the mean.
Protein binding and developed force was plotted against TnI
concentration or Ca2+, respectively, and fit with a logistic
sigmoid function mathematically equivalent to the Hill equation
to determine 50% maximal binding or force as previously
described. Results of Tn exchange and force development
experiments were compared by One-way ANOVA with Tukey’s
post-hoc test. p< 0.05 was considered statistically significant.
RESULTS
The Functional Integration of TnI Ser-23/24
and Ser-150 Phosphorylations Is
Determined by Their Differential Protein
Interactions within the Thin Filament
Our previous studies demonstrate functional integration of
TnI phosphorylations exhibit different contractile function
than predicted from the effect of each phosphorylation in
isolation (Nixon et al., 2012, 2014; Salhi et al., 2014). Functional
integration of Ser-150 with Ser-23/24 phosphorylation restores
WT-like Ca2+-sensitivity (normal force) while maintaining
accelerated thin filament Ca2+ dissociation (accelerated
relaxation) (Nixon et al., 2012, 2014). We first investigated
if altered thin filament protein interactions within a single
regulatory unit were sufficient to explain this functional
integration. Toward this end we employed a mathematical
model based on several biochemical states of TnC (apo or
bound to Ca2+, Mg2+, and/or TnI) recently developed by
the Davis laboratory to identify mechanisms involved in TnI
phosphorylation integration (Siddiqui et al., 2016). Changes
in the hill coefficient and cooperativity are not incorporated
into the model. This model identified that Ser-23/24 and
Ser-150 phosphorylations differentially modulate regulation of
contraction by altering the affinity of different TnI thin filament
interactions. By simply accelerating the dissociation of TnI
from TnC (Figure 1A), the model recapitulates the biochemical
effects of TnI Ser-23/24 phosphorylation on steady-state Ca2+
binding and Ca2+ dissociation in thin filament and the isolated
Tn complex (Figures 1B,C). Our model further asserts that
Ser-150 phosphorylation utilizes a separate mechanism by
slowing the dissociation of Ca2+ from TnC-TnI and increasing
the availability of TnI for TnC (Figure 1A). Making only these
two alterations are sufficient to accurately model the increase in
Ca2+ sensitivity and decrease in Ca2+ dissociation induced by
Ser-150 phosphorylation in both the Tn and thin filament state
(Figures 1B,C). Based upon these results we hypothesized that
modulation of these separate TnI binding affinities is sufficient
to reconcile TnI Ser-23/24 and Ser-150 phosphorylation
functional integration. Indeed, the model demonstrates that
combination of these two phosphorylation mechanisms is
sufficient to recapitulate the Ser-150 induced blunting of
Ser-23/24 desensitization while maintaining accelerated thin
filament Ca2+ dissociation in both isolated Tn and the thin
filament (Figures 1B,C), similar to our previously published data
for that of Tn S23/24/150D (Nixon et al., 2014, 2012).
TnI availability in the model is dependent on several
interactions TnI may have in the thin filament and allows
us to predict the molecular mechanisms responsible for Tn
mediated modification alteration of thin filament regulation. To
mechanistically understand the bases of TnI phosphorylation
effects predicted by the model, we employed a solid-phase
protein binding assay to measure the affinity of cardiac TnI
for actin under different pseudo-phosphorylated states. Protein
binding experiments demonstrate that while purified cardiac
Ser-23/24 pseudo-phosphorylated TnI does not alter the actin
binding affinity, Ser-150 pseudo-phosphorylation decreases
TnI-actin binding by 3.3-fold (TnI concentration required for
50% maximum binding to actin: TnI WT = 16.0 ± 0.5 nM,
TnI S23/24D = 15.0 ± 0.4 nM, TnI S150D = 52.9 ± 2 nM; TnI
WT vs. TnI S150D = p < 0.05) (Figure 2). According to the
model, we hypothesized that the Ser-150-mediated decrease in
TnI actin affinity would be maintained upon integration with
Ser-23/24 phosphorylation. Our protein binding data confirms
that TnI S23/24/150D still exhibits a 2.6-fold decrease in actin
binding affinity compared to WT TnI (TnI concentration
required for 50% maximum binding to actin: TnI S23/24/150D
= 41.2 ± 0.7 nM; TnI WT vs. TnI S23/24/150D = p < 0.05)
(Figure 2). This decreased affinity of TnI Ser-150 pseudo-
phosphorylation, but not Ser-23/24 pseudo-phosphorylation for
actin demonstrates that Ser-23/24 and Ser-150 phosphorylation
can differentially modulate the binding of TnI to actin, validating
model predictions that Ser-23/24/150 functional integration is at
least in part based on different molecular mechanisms of the two
phosphorylations to modulate TnI interactions within the thin
filament.
Functional Integration of TnI Ser-23/24 and
Ser-150 Pseudo-Phosphorylation in Rat
Myocytes
Several studies have demonstrated that Ser-23/24
phosphorylation decreases Ca2+-sensitivity of skinned
cardiac muscle preparations (Robertson et al., 1982; Zhang
et al., 1995; Biesiadecki et al., 2007). Previous work from
our lab demonstrated that Ser-150 phosphorylation increases
Ca2+-sensitivity of force development in isolation and its
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FIGURE 1 | TnI Ser-23/24 and Ser-150 differentially alter thin filament activation through different TnI mediated mechanisms. (A) Diagrammatic
representation of the biochemical states in the Siddiqui et al. model (Siddiqui et al., 2016). The rates altered to fit our previous biochemical data for thin filaments
containing TnI Ser-150 (red arrow) and Ser-23/24 phosphorylation (blue arrow) are identified. Model simulation of (B) steady-state Ca2+-binding and (C) Ca2+
dissociation from TnC in human thin filaments containing WT (Tn WT, black dashed line), Ser-150 pseudo-phosphorylated (Tn S150D, red dashed line), Ser-23/24
pseudo-phosphorylated (Tn S23/24D, blue dashed line) or Ser-23/24 and Ser-150 pseudo-phosphorylated (Tn S23/24/150D, gray dashed line) TnI demonstrating a
similar effect of these phosphorylations to our previously reported biochemical measurements (Nixon et al., 2014).
functional integration blunts Ser-23/24 phosphorylation
mediated desensitization following exchange into skinned
cardiac trabeculae (Nixon et al., 2012, 2014). Previously we
demonstrated the pseudo-phosphorylation of TnI at both
Ser-23/24 and Ser-150 by mutation to Asp alters Ca2+ dependent
force identical to that of actual phosphate at these sites
(Biesiadecki et al., 2007; Nixon et al., 2012). To investigate the
functional integration of Ser-23/24 and Ser-150 phosphorylation
in the isolated skinned rat myocyte system, we measured Ca2+
dependent force development in left ventricular rat skinned
myocytes exchanged with human cardiac Tn containing either
WT TnI (Tn WT), S23/24 pseudo-phosphorylated TnI (Tn
S23/24D), S150 pseudo-phosphorylated TnI (Tn S150D) or
S23/24/150 pseudo-phosphorylated TnI (Tn S23/24/150D).
Following exchange, the percent of exogenous Tn incorporated
into all measured myocyte preparations was determined by
Western blot, as the exogenous human cardiac TnI migrates
faster by SDS-PAGE than endogenous rat cardiac TnI. Exchange
quantification demonstrated an average of 57% exogenous Tn
incorporation that was not different for any of the different Tn’s
exchanged (% exchange: rat Tn WT = 60.5 ± 7.5%, human
WT Tn = 55.3 ± 1.8%, Tn S23/24D = 57.0 ± 5.0%, Tn S150D
= 58.0 ± 4.5%, Tn S23/24/150D = 62.0 ± 3.8%; p > 0.05)
(Figure 3). Furthermore, the exchange of human Tn WT did
not alter Ca2+-sensitivity compared to cells exchanged with Tn
containing rat WT cardiac TnI, rat cardiac Myc tagged WT TnT
and rat WT TnC (RcTn WT) (Figure 4 and Table 1). Consistent
with previous findings, exchange with Tn S23/24D decreased
Ca2+-sensitivity of force development, while exchange with Tn
S150D increased Ca2+-sensitivity compared to TnWT (Figure 4
and Table 1) (Nixon et al., 2012). The Ca2+-sensitivity of cells
exchanged with Tn S23/24/150D was not different from Tn WT,
consistent with previous findings that S150D blunts Ser-23/24
mediated desensitization (Figure 4 and Table 1). These data
demonstrate that Ser-23/24 and Ser-150 pseudo-phosphorylation
impart different effects on Ca2+-sensitive force development
in the skinned rat myocyte system, consistent with previous in
vitro and trabeculae data (Nixon et al., 2012, 2014). Additionally,
Ser-150 pseudo-phosphorylation is able to blunt the Ser-23/24
mediated desensitization when these phosphorylations occur on
the same TnI molecule in the skinned rat myocyte.
Ca2+ Sensitive Force Development Is
Dependent On the Amount of TnI
Phosphorylation Present
The functional effects of integrated TnI phosphorylations may be
complexly related to the amount of TnI phosphorylation present.
To determine if the relationship between Ca2+-sensitivity and
the amount of phosphorylation present is linear for both TnI
Ser-23/24 and Ser-150, we measured the Ca2+-dependent force
development in left ventricular rat skinned myocytes. Myocytes
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FIGURE 2 | TnI Ser-150, but not Ser-23/24, pseudo-phosphorylation
decreases TnI binding to actin. Average solid-phase TnI-actin protein
binding data demonstrating that compared to WT (TnI WT: black circle, solid
line), the pseudo-phosphorylation of Ser-150 (TnI S150D: black Square,
dashed line) and Ser-23/24/150 (TnI S23/24/150D: gray diamond, solid line)
decrease TnI binding to actin while the pseudo-phosphorylation of Ser-23/24
(TnI S23/24D: gray triangle, dashed line) do not. Protein binding assays were
conducted in triplicate wells and repeated.
were exchanged with a mixture of 50% human cardiac Tn
WT and either 50% Tn S23/24D (Tn WT+S23/24D) or 50%
Tn S150D (Tn WT+S150D). Western blot for cardiac TnI
demonstrated the incorporation of 51.7 ± 3.3% WT+S23/24D
and 56.5 ± 6.9% WT+S150D exogenous Tn (p > 0.05)
(Figure 3). While we cannot directly determine the percent
exchange of each exogenous Tn complex in the mixture, we
assume similar exchange as we observed for Tn S23/24D
and Tn S150D exchange (Figure 3). Following exchange with
Tn WT+S23/24D we observed half the decrease in pCa50
observed for Tn S23/24D exchange compared to Tn WT
exchange (change in pCa50 from Tn WT: Tn S23/24D = 0.11,
WT+S23/24D = 0.05) (Figure 5 and Table 1). We observed
similar results following exchange with Tn WT+S150D, in
which the myofilament was only half as sensitized compared to
exchange with Tn S150D alone (change in pCa50 from Tn WT:
Tn S150D = 0.17, Tn WT+S150D = 0.1; p < 0.05) (Figure 5
and Table 1). These data demonstrate that the magnitude
of phosphorylation dependent change in Ca2+-sensitive force
development is related to the amount of TnI phosphate present
at the TnI Ser-23/24 or Ser-150 residues.
TnI Ser-23/24 and Ser-150
Pseudo-Phosphorylation Exhibit
Functional Integration When On Different
TnI Molecules
The overwhelming majority of studies to date have primarily
determined the combined function of multiple phosphorylations
on the same TnI molecule. We investigated if the different
molecular mechanisms utilized by Ser-23/24 and Ser-150
phosphorylation integrate when occurring on different Tn
molecules. To this end, we exchanged cells with Tn containing
50% TnI S23/24D and 50% TnI S150D (Tn S23/24D+S150D)
that resulted in an average of 56.8 ± 7.5 percent total
exogenous Tn exchange. Thus, the Tn S23/24D+S150D exchange
group is expected to result in cells containing ∼25% TnI
S23/24D, ∼25% S150D and ∼50% endogenous WT Tn in
the myofilament. Calcium sensitivity of cells exchanged with
Tn S23/24D+S150D was not different from those exchanged
with Tn S23/24/150D, even though the pseudo-phosphorylations
occurred on separate Tn molecules (Figure 6 and Table 1). Thus,
these data demonstrate that pseudo-phosphorylation of TnI
molecules at Ser-150 integrate to blunt the Ca2+ desensitizing
effects of Ser-23/24 pseudo-phosphorylation even when these
two phosphorylated residues are present on different TnI
molecules. Therefore, the molecular mechanisms responsible
for phosphorylation functional integration to differentially affect
heart function can integrate across different Tn’s along the
myofilament.
DISCUSSION
The phosphorylation of different TnI residues is altered by
physiological and pathological stress and therefore the combined
function of multiple TnI phosphorylations plays a critical role to
differentially modulate cardiac function in both the normal and
diseases states. Our current study aimed to elucidate underlying
mechanisms utilized by Ser-23/24 and Ser-150 phosphorylation.
Our findings demonstrate that: (1) The integrated function of TnI
Ser-23/24 and Ser-150 phosphorylation is dependent in part upon
their regulation of different TnI protein-protein interactions
within the thin filament. TnI Ser-23/24 phosphorylation alters
the dissociation of the TnI C-terminus from TnC, while
TnI Ser-150 phosphorylation alters binding of the TnI C-
terminus to actin and slows the dissociation of Ca2+ from
TnC in the presence of TnI. (2) TnI Ser-23/24 or Ser-150
phosphorylation occupancy linearly alters Ca2+-sensitive force
development. (3) The mechanisms utilized by Ser-23/24 and Ser-
150 phosphorylation integration to affect Ca2+-sensitive force
development occur both when on the same and separate Tn
molecules along the myofilament.
Regulatory Mechanisms of TnI Ser-23/24
and Ser-150 Phosphorylation
TnI Ser-23/24 phosphorylation decreases Ca2+-sensitive force
production (Figure 4) (Solaro et al., 1976; Kranias and Solaro,
1982; Zhang et al., 1995; Nixon et al., 2012). The cardiac TnI
N-terminal region containing the Ser-23/24 residues interacts
with the N-lobe of TnC (Abbott et al., 2001). The structural
basis for Ser-23/24 phosphorylation to decrease Ca2+-sensitivity
is proposed to be through alteration of this interaction between
the TnI N-terminus and TnC. Peptide binding studies have
supported this hypothesis by demonstrating a decreased binding
affinity of TnI N-terminal peptides that contain phosphorylated
Ser-23/24 to TnC (Ferrières et al., 2000). NMR studies also
complement these findings, demonstrating the TnI N-terminus
makes contacts with the N-terminal domain of TnC near the
regulatory Ca2+-binding site (Finley et al., 1999; Gaponenko
et al., 1999; Abbott et al., 2000). These contacts are altered
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FIGURE 3 | Tn exchange into skinned cells is similar for all investigated TnI pseudo-phosphorylations. (A) Representative TnI Western blot of myocytes
following exchange demonstrates a similar presence of the faster migrating exogenous human cardiac TnI compared to the slower migrating endogenous rat cardiac
TnI in all Tn’s investigated. (B) Densitometry analysis of Western blots demonstrates the average percent of each exchanged exogenous Tn is not different. Control;
purified recombinant rat WT cardiac TnI.
when Ser-23/24 are substituted with phosphomimetics (Finley
et al., 1999; Ward et al., 2004; Hwang et al., 2014). The
mechanisms by which alteration of TnI N-terminus binding to
TnC is propagated through the Tn complex to affect Ca2+-
sensitivity remain unclear. Current data supports that the Ser-
23/24 phosphorylation can act either by directly destabilizing
Ca2+ binding to the TnC regulatory site or indirectly by
modulating binding affinities of the TnI C-terminal region to
TnC or actin (switch peptide or inhibitory peptide binding,
respectively). Data from our model and binding studies suggest
that Ser-23/24 phosphorylation acts, at least in part, by altering
the TnI-TnC interaction to increase the dissociation of TnI from
TnC-Ca2+ (Figure 1). Altering the dissociation of TnI from
TnC-Ca2+ is sufficient to recapitulate Ser-23/24 phosphorylation
biochemical data and is consistent with a proposed intra-
molecular interaction between TnI subdomains, whereby Ser-
23/24 phosphorylation places the N-terminus in a conformation
to interact with the basic residues on the C-terminal TnI
regulatory region near the switch peptide (Howarth et al., 2007;
Warren et al., 2009).
TnI Ser-150 phosphorylation increases Ca2+-sensitive force
production (Buscemi et al., 2002; Nixon et al., 2012; Oliveira
et al., 2012). This Ser-150-mediated increase in myofilament
Ca2+-sensitivity has been proposed to occur by modulating
the affinity of the TnI inhibitory peptide binding to actin
and/or switch peptide binding to the TnC N-lobe (Ouyang
et al., 2010; Nixon et al., 2012). The location of Ser-150
immediately adjacent to the TnI inhibitory peptide has potential
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FIGURE 4 | TnI Ser-150 blunts Ser-23/24 pseudo-phosphorylation in Tn exchanged single rat cardiac myocytes. Average normalized force-pCa
measurements of Tn exchanged single cardiac myocytes. (A) Myocytes exchanged with WT human cardiac Tn (Tn WT: black circle, solid line; n = 8) or WT rat cardiac
Tn (RcTn WT: gray triangle, dashed line; n = 8) exhibit similar Ca2+-sensitive force development. (B) The Ca2+-sensitive force development in myocytes exchanged
with Tn containing Ser-150 pseudo-phosphorylated TnI (Tn S150D: gray triangle, dashed line; n = 7) is increased while Ser-23/24 pseudo-phosphorylated TnI (Tn
S23/24D: gray square, dashed line; n = 7) is decreased compared to Tn containing WT TnI (Tn WT: black circle, solid line; n = 8) exchange. (C) The Ca2+-sensitive
force development in myocytes exchanged with Tn containing Ser-23/24/150 pseudo-phosphorylated TnI (Tn S23/24/150D: gray triangle, solid line; n = 8) is identical
to those with Tn WT exchange. (D) Comparison of pCa50. *p < 0.05 vs. WT Tn.
TABLE 1 | Force development in skinned myocytes.
Tn pCa50 Hill Fmax n
RcTn WT 5.58 ± 0.01d,e 2.51 ± 0.13d 115.3 ± 13.52 8
100% Tn WT 5.58 ± 0.02d,e 3.14 ± 0.14d 89.53 ± 10.71 8
Single Tn Tn S23/24D 5.46 ± 0.03a,b,c,e 4.04 ± 0.27a,b,c,e 71.15 ± 6.33b 7
Exchange Tn S150D 5.74 ± 0.02a,b,c,d 2.34 ± 0.10d 99.41 ± 7.68 7
Tn S23/24/150D 5.57 ± 0.02d,e 3.09 ± 0.15d 83.00 ± 7.79 8
50/50% Tn WT+S23/24D 5.53 ± 0.03e 3.41 ± 0.21d,e 100.67 ± 12.91 7
Dual Tn Tn WT+S150D 5.68 ± 0.02a,b,c,d,e 2.15 ± 0.13b,c,d 82.87 ± 5.70 9
Exchange Tn S23/24D+S150D 5.59 ± 0.02d,e 2.87 ± 0.30d 86.20 ± 4.79 7
Values are mean ± SEM. pCa50, −log[Ca
2+ ] at 50% force development; Hill, Hill coefficient; Fmax , maximal force in µN/mm
2; n, number of single myocytes measured from at least
three different exchanges per group. One-way ANOVA demonstrates a significant interaction. p < 0.05.
aSignificantly different vs. Tn WT.
bSignificantly different vs. RcTn WT.
cSignificantly different vs. Tn S23/24/150D.
dSignificantly different vs. Tn S23/24D.
eSignificantly different vs. Tn S150D.
for phosphate incorporation to repel the TnI C-terminus from
actin and/or promote the binding of the switch peptide to TnC.
Enhanced TnC-TnI switch peptide binding is supported by FRET
experiments indicating that Ser-150 pseudo-phosphorylation
shortens inter-site distances between TnI and TnC (Ouyang
et al., 2010). In addition, data from our lab demonstrating that
Ser-150 phosphomimetic substitution increases Ca2+-sensitivity
in isolated Tn (Nixon et al., 2014), supporting that Ser-150
phosphorylation enhances the binding of the TnI switch peptide
to TnC in the absence of interactions with the actin filament.
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FIGURE 5 | Single myocytes exchange with 50% pseudo-phosphorylated TnI exhibit half the phosphorylation mediated sensitivity change. Average
normalized force-pCa measurements of Tn exchanged single cardiac myocytes. (A) The decrease in Ca2+-sensitive force development of myocytes exchanged with
Tn containing 50% WT and 50% Ser-23/24 pseudo-phosphorylated TnI (Tn WT+S23/24D: black square, dashed line; n = 7) is half that of myocytes exchanged with
Tn containing Ser-23/24 pseudo-phosphorylated TnI (Tn S23/24D: gray triangle, dashed line; n = 7) compared to WT (Tn WT: black circle, solid line; n = 8) exchange.
(B) The increase in Ca2+-sensitive force development of myocytes exchanged with Tn containing 50% WT and 50% Ser-150 pseudo-phosphorylated TnI (Tn
WT+S150D: black square, dashed line; n = 9) is half that of myocytes exchanged with Tn containing Ser-150 pseudo-phosphorylated TnI (Tn S150D: gray triangle,
dashed line; n = 7) compared to Tn WT exchange. (C) Comparison of pCa50. *p < 0.05 vs. WT Tn.
Enhanced binding of the switch peptide to TnC would contribute
to a stabilization of the TnC-Ca2+ affinity and a decrease in Ca2+
dissociation, as suggest by ourmodel (Figure 1). Current findings
from our model further suggest that Ser-150 phosphorylation
destabilizes the interaction of the TnI C-terminus with actin to
promote thin filament activation. This mechanism is validated
by our solid-phase protein binding experiments in which Ser-150
pseudo-phosphorylation decreases the binding affinity of isolated
TnI to actin (Figure 2). Thus, we propose that the prominent TnI
affinities acted upon by Ser-23/24 and Ser-150 phosphorylation
differ in that phosphorylated Ser-23/24 alters the affinity of the
switch peptide for TnC by accelerating TnI dissociation from
TnC-Ca2+. In contrast, while Ser-150 phosphorylation may alter
other TnI affinities in the thin filament, we demonstrate that
the decreased affinity of pseudo-phosphorylated TnI at Ser-150
for actin is sufficient to elicit the observed increased calcium
sensitivity.
Although the structural basis for the integrated effects of TnI
of Ser-150 and Ser-23/24 phosphorylation remains unclear, our
data provides significant mechanistic insight into this functional
integration. Previous work indicates the TnI C-terminus is
located in close proximity to the TnI N-terminus in the activated
Tn complex (Howarth et al., 2007; Warren et al., 2009). This
proximity of the TnI N-terminus containing Ser-23/24 to the
C-terminus containing Ser-150 provides a mechanism by which
Ser-150 and Ser-23/24 phosphorylation may interact to produce
an integrated effect on Ca2+-sensitivity when on the same
TnI molecule (Nixon et al., 2012). Our current data, however,
demonstrates that phosphorylation of Ser-150 and Ser-23/24 on
the same TnI molecule is not necessary to produce the Ca2+-
sensitivity blunting effect (Figure 5). Although a direct TnI N-
C terminal interaction may occur, we demonstrate Ser-23/24
and Ser-150 phosphorylation functional integration also utilizes
separate, distinct molecular mechanisms that modulate TnI
protein-protein interactions within the thin filament to regulate
heart function. These data present a model in which a cumulative
effect of each Tn phosphorylation along the thin filament must be
considered to contribute to the overall observed Ca2+-sensitivity
and contractile effects.
TnI Phosphorylation Functional Integration
Effects On Myofilament Regulation
A large subset of the literature has described how isolated
Tn modifications affect Ca2+-mediated force development. The
phosphorylation of TnI is significant considering that altered
Ca2+ sensitivity has been shown to underlie physiological
modulation of cardiac output as well as potential adaptive
and maladaptive responses in cardiac dysfunction (Zakhary
et al., 1999; Kobayashi and Solaro, 2005; Zhang et al., 2012;
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FIGURE 6 | Single myocytes exchanged with Ser-150 and Ser-23/24
pseudo-phosphorylation on different Tn exhibit Ca2+-sensitivity
identical to both TnI pseudo-phosphorylations on the same Tn. (A)
Average normalized force-pCa measurements of Tn exchanged single cardiac
myocytes exchanged with Tn containing Ser-23/24 and Ser-150
pseudo-phosphorylation on the same TnI (Tn S23/24/150D: gray triangle,
solid line; n = 8) or exchanged with 50% Ser-23/24 and 50% Ser-150
pseudo-phosphorylated TnI on different Tn (Tn S23/24D+S150D: black
square, dashed line; n = 7) both exhibit identical Ca2+ dependent force
development to those exchanged with WT TnI (Tn WT: black circle, solid line; n
= 8). (B) Comparison of pCa50.
Lang et al., 2015). While Ser-150 has been shown to be
phosphorylated by p-21 activated kinase and AMP-activated
protein kinase (AMPK) in vitro, AMPK seems to be the likely
relevant kinase in vivo (Buscemi et al., 2002; Sheehan et al.,
2009; Oliveira et al., 2012). Previous studies have demonstrated
AMPK associates with TnI and phosphorylates Ser-150, and
isolated hearts perfused with an AMPK activator increase Ser-
150 phosphorylation (Nixon et al., 2012; Oliveira et al., 2012).
Several reports have demonstrated the importance of AMPK
signaling in cardiac metabolism and contractility. Knockout or
inhibition of AMPK has been shown to lead to cardiomyopathy
and/or altered contraction concurrent with decreases in TnI
Ser-150 phosphorylation (Chen et al., 2014; Sung et al., 2015).
It remains to be resolved if the pathological effects of AMPK
inactivation result from metabolic dysregulation, contractile
deficiencies or both. We have demonstrated the effect of Ser-150
phosphorylation to increase myofilament calcium sensitivity
of force development in skinned trabeculae, increase steady-
state calcium binding to isolated troponin, and slow calcium
dissociation from TnC on the thin filament (Nixon et al., 2012,
2014). Additionally, significant evidence has pointed to a role
for Ser-150 phosphorylation under pathophysiologic conditions.
Ser-150 phosphorylation is increased following acute ischemia
in the murine heart and the calcium sensitization induced
by Ser-150 phosphorylation was shown to blunt myofilament
calcium desensitization caused by acidic pH (Nixon et al.,
2014). As such, Ser-150 phosphorylation may play an important
role to increase calcium sensitivity and force development
resulting in preserving myocardial function under pathological
stress during ischemia. The functional integration between Ser-
23/24 and Ser-150 phosphorylation also presents a potentially
important interplay in vivo. Previous work has demonstrated
chronic beta adrenergic stimulation results in increased TnI
Ser-150 phosphorylation (Taglieri et al., 2011). Similarly, both
Ser-23/24 and Ser-150 phosphorylation are increased during
myocardial ischemia (Nixon et al., 2014). Together these findings
suggest cross-talk between beta adrenergic and AMPK mediated
signaling to increase cardiac output by accelerating thin filament
deactivation/muscle relaxation while maintaining normal force
development. Future work is needed to investigate the signaling
cross-talk between B-adrenergic and AMPK signaling, functional
integration of Ser-23/24 and Ser-150 phosphorylation and their
effects on in vivo cardiac contractility and energy metabolism.
Whether these isolated functional effects of Ser-150
phosphorylation are maintained in the integrated network
alongside other phosphorylation events remains understudied.
Our previous work demonstrated functional integration of TnI
Ser-150 with Ser-23/24 phosphorylation blunted themyofilament
desensitization induced by TnI Ser-23/24 phosphorylation alone
(Figure 4) (Nixon et al., 2012, 2014). In the current study we
assessed the contribution of TnI Ser-23/24 and Ser-150 integrated
TnI phosphorylation by analyzing their effects on Ca2+-sensitive
force development. We demonstrate that the overall observed
Ca2+-sensitivity is proportional to the amount of phosphorylated
TnI present at up to ∼ 57% exogenous Tn exchange (Figure 3).
Although we did not achieve 100% exchange of exogenous Tn
into our single myocyte system, previous studies have suggested
50–60% exchange is sufficient to elicit maximal effects on Ca2+-
sensitivity for Ser-23/24 phosphorylation (Wijnker et al., 2013).
Thus, it is possible that the proportional functional effects of
TnI phosphorylation exist only within a linear range of exchange
below 60%. In addition, while we detected a degradation
fragment of TnI in our exchanged cells, the presence of this
fragment was variable amongst TnI exchange groups and did not
appear to correlate with changes in pCa50 nor maximal tension
values. The appearance of a TnI cleaved product is consistent
with previous studies demonstrating that approximately 13% of
the total TnI exists as this TnI fragment in the normal rat heart
(Yu et al., 2001; Barbato et al., 2005). Nevertheless, because these
changes in Ca2+-sensitive force development are linear with the
amount of phosphorylation present, our data suggests that this
is not a mechanism contributing the different functional effects
of Ser-23/24 and Ser-150 phosphorylation upon integration.
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As such, quantification of multiple TnI phosphorylations
is necessary to infer the effect of TnI phosphorylation on
the overall observed Ca2+-sensitivity in its relation to force
production.
Previously we demonstrated functional integration of TnI
Ser-23/24 and Ser-150 pseudo-phosphorylation occurred when
both phosphorylations were on the same TnI molecule (Nixon
et al., 2012, 2014). We now demonstrate that TnI Ser-
23/24 and Ser-150 pseudo-phosphorylation integration similarly
affects steady-state Ca2+-sensitive force development whether
these phosphorylations are on the same or different TnI
molecules (Figure 6). This suggests that the TnI Ser-23/24
and Ser-150 phosphorylation integration of Ca2+-sensitive force
development function occurs through a cumulative effect of
separate Tn contributions along the thin filament. Our current
data further demonstrates that these phosphorylations exhibit
complex functional integration both when on the same TnI
molecule as well as when on different TnI molecules. These
relationships may not be universal for other measurements of
myofilament function, such as maximal force, Ca2+ dissociation,
length dependent activation, etc. and may be further dependent
upon the specific TnI phosphorylation. In fact, we previously
demonstrated TnI Ser-23/24 and Ser-150 phosphorylation
integration functions to differently alter Ca2+-sensitivity and
Ca2+ dissociation. That is, while the integration of Ser-23/24
and Ser-150 exhibit expected Ca2+-sensitivity, Ca2+ dissociation
remains unexpectedly accelerated (Nixon et al., 2012, 2014).
Likewise, we have also demonstrated the functional integration
of TnI Ser-23/24 with Tyr-26 phosphorylation, where the
combination of these phosphorylations does not exhibit an
expected effect on Ca2+-sensitivity but does exhibit the expected
further accelerated Ca2+ dissociation (Salhi et al., 2014). Further
experiments are ultimately needed to define the integrated effects
of other TnI phosphorylations on these different functional
measurements.
In all, our current study demonstrates that the apparent
magnitude and rates of myofilament activation and deactivation
are dependent on multiple mechanisms functioning within
Tn that comprise intricate protein-protein interactions. We
demonstrate different TnI phosphorylations can affect varied
mechanisms within Tn that differentially alter specific contractile
functions (Ca2+ binding, kinetics, force development, etc.). It
is therefore the combination of each TnI phosphorylation’s
affect on different mechanisms within Tn to alter myofilament
activation that imparts functional integration. The integrative
role of multiple TnI phosphorylations thus allows for the
complex fine-tuning of cardiac function through Tn.
CONCLUSION
Ultimately, TnI regulation of cardiac function is dependent
upon the homeostatic balance between the mechanistic protein-
protein interactions of each phosphorylation on Tn units along
the myofilament. Our findings demonstrate that the different
effects of Ser-23/24 and Ser-150 phosphorylation upon functional
integration combination are the result of distinct Tn mediated
mechanisms that alter different Ca2+ regulated TnI interactions
within the thin filament. We further demonstrate that the
blunting effect of TnI Ser-150 phosphorylation integration on
Ser-23/24 dependent desensitization is recapitulated in the
single myocyte system of Ca2+-sensitive force development
and this effect of phosphorylation on Ca2+-sensitivity is
proportional to the amount of TnI phosphorylation present.
Finally, our data demonstrates that TnI phosphorylations with
divergent properties can functionally interact while on separate
Tn molecules along the myofilament to produce a complex
modulation of overall observed Ca2+-sensitive force production.
To fully understand the contractile outcome of multiple TnI
phosphorylations it is therefore important to investigate TnI
phosphorylation alterations in their integrated state as they occur
in the heart.
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